'(2-hydroxy-2-(4-hydroxy-3-hydoxymethylphenyl)-ethylamino)-propyl!phenyl derivatives as beta2 agonists

Details for Australian Patent Application No. 2004237952 (hide)

Owner Pfizer Inc.

Inventors Lane, Charlotte Alice Louise; Lewthwaite, Russell Andrew; Glossop, Paul Alan; Bunnage, Mark Edward

Agent Allens Patent & Trade Mark Attorneys of Level **** Streets Sydney NSW 2000 Australia

Pub. Number AU-A-2004237952

PCT Pub. Number WO2004/100950

Priority 03010944.1 15.05.03 EP; 0329874.2 23.12.03 GB

Filing date 29 April 2004

Wipo publication date 25 November 2004

International Classifications

A61K 031/4402 - only substituted in position 2, e.g. pheniramine, bisacodyl

C07C 237/20 Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups

C07D 217/02 Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems

A61K 031/4035

C07D 213/40 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07C 311/16 Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

A61K 031/472 - Non-condensed isoquinolines, e.g. papaverine

C07D 209/44 Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 031/164 - of a carboxylic acid with an aminoalcohol, e.g. ceramides

Event Publications

10 November 2005 PCT application entered the National Phase

  PCT publication WO2004/100950 Priority application(s): WO2004/100950

15 May 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004237958-Hard gelatin capsule containing titanium oxide with a controlled particle size and process for producing the same

2004237951-Therapeutic combinations of atypical antipsychotics with GABA modulators, anticonvulsants or benzodiazapines